ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

PHASE3TerminatedINTERVENTIONAL

Enrollment

177

Participants

Timeline

Start Date

August 29, 2016

Primary Completion Date

January 30, 2019

Study Completion Date

January 30, 2019

Conditions

Agitation in Dementia, Including Alzheimer's Disease

Interventions

DRUG

ITI-007

DRUG

Placebo

Trial Locations (26)

Sun City

Little Rock

Rogers

Costa Mesa

Glendale

Irvine

Lemon Grove

Long Beach

Oceanside

Riverside

Santa Ana

Hallandale

Hialeah

Miami

Orlando

Suwanee

Honolulu

Las Vegas

Berlin

Marlton

Toms River

Brooklyn

Staten Island

Centerville

Dayton

San Antonio